Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-25-009934

CVP, JAPAC sold 1,019 shares at $84.03 ($85,625)

  • CVP, JAPAC acquired 1,019 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lippis Daniel J. CVP, JAPAC 2025-12-12 Option exercise 10b5-1 +1,019 $59.26 $60,383 23,020.91 D
Lippis Daniel J. CVP, JAPAC 2025-12-12 Sale 10b5-1 −1,019 $84.03 $85,625 22,001.91 D
Derivatives
Lippis Daniel J. CVP, JAPAC 2025-12-12 Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 −1,019 5,095 D
Open-market sales · 1,019 sh · avg $84.03 · $85,625
Loading xslF345X05/doc4.xml…